Howard Feldman, MD, FRCP (C)
University of California, San Diego
- 2 editions
- 2 talks
- 1 recording
2023
- Public Forum Drugs likely to Receive Full FDA Approval in 2023/24: Efficacy, Adverse Effects, Mode of Delivery, Cost
2022
- Symposium, Day 2 Improved Designs for AD Clinical Treatment Trials
Degrees and affiliation are current where known; the program pages show affiliations as they were each year.